Experimental autoimmune encephalomyelitis (EAE) as a model for multiple sclerosis (MS)

Cites (395)

Items 201–395 of 395

1. Predictability of FTY720 efficacy in experimental autoimmune encephalomyelitis by in vivo macrophage tracking: Clinical implications for ultrasmall superparamagnetic iron oxide‐enhanced magnetic resonance imaging
   Martin Rausch, PETER C. HIESTAND, Carolyn A. Foster, Diana Kindler, Catherine Cannet, Markus Rudin · 2004 · Journal of Magnetic Resonance Imaging
2. Multiple sclerosis: a practical overview for clinicians
   Konrad Rejdak, Sam Jackson, Gavin Giovannoni · 2010 · British Medical Bulletin
3. TGF-β signaling in dendritic cells is a prerequisite for the control of autoimmune encephalomyelitis
   Yasmina Laouar, Terrence Town, David Jeng, Elise Tran, Yisong Y. Wan, Vijay Kumar Kuchroo, Richard Anthony Flavell · 2008 · Proceedings of the National Academy of Sciences
4. Modulation of effector cell functions in experimental autoimmune encephalomyelitis by leflunomide— mechanisms independent of pyrimidine depletion
   Thomas Korn, Tim Magnus, Klaus Viktor Toyka · 2004 · Journal of Leukocyte Biology
5. Immunomodulation of experimental autoimmune encephalomyelitis by oral administration of copolymer 1
   Dvora Teitelbaum, Ruth Arnon, Michael Sela · 1999 · Proceedings of the National Academy of Sciences
6. Randomized study of antibodies to IFN-g and TNF-a in secondary progressive multiple sclerosis
   Simon V. Skurkovich, А. Н. Бойко, I Beliaeva et al. · 2001 · Multiple Sclerosis Journal
7. TCR usage in human and experimental demyelinating disease
   David A. Hafler, Mark G. Saadeh, Vijay Kumar Kuchroo, Edgar Louis Milford, Lawrence Steinman · 1996 · Immunology Today
8. B cells from glatiramer acetate-treated mice suppress experimental autoimmune encephalomyelitis
   Mrinalini Kala, Susan N. Rhodes, Wen-Hua Piao, Fu‐Dong Shi, Denise I. Campagnolo, Timothy L. Vollmer · 2009 · Experimental Neurology
9. Modulation of Cannabinoid Receptor Activation as a Neuroprotective Strategy for EAE and Stroke
   Ming Zhang, Billy R. Martin, Martin W. Adler, Raj J. Razdan, Weimin Kong, Doina Ganea, Ronald F. Tuma · 2009 · Journal of Neuroimmune Pharmacology
10. Motor neuron pathology in experimental autoimmune encephalomyelitis: studies in THY1-YFP transgenic mice.
    Peter Bannerman, A. Hahn, S. Ramirez, M. Morley, C. Bonnemann, S. Yu, Guang-Xian Zhang, A. Rostami, D. Pleasure · 2005 · Brain : a journal of neurology
11. Cytokines in the central nervous system of mice during chronic relapsing experimental allergic encephalomyelitis
    David J Baker, Janet K. O'Neill, J.L. Turk · 1991 · Cellular Immunology
12. Helminth Antigens Modulate Immune Responses in Cells from Multiple Sclerosis Patients through TLR2-Dependent Mechanisms
    Jorge Daniel Correale, Mauricio Farez · 2009 · The Journal of Immunology
13. Refining genetic associations in multiple sclerosis
    2008 · The Lancet Neurology
14. Glatiramer acetate in combination with minocycline in patients with relapsing—remitting multiple sclerosis: results of a Canadian, multicenter, double-blind, placebo-controlled trial
    L Metz, David K.B. Li, Anthony L. Traboulsee, Mary Lou Myles, Pierre Duquette, J. Godin, Michel Constantin, Voon Wee Yong · 2009 · Multiple Sclerosis Journal
15. Histamine and histamine receptors in pathogenesis and treatment of multiple sclerosis
    Farhad Jadidi‐Niaragh, Abbas Mirshafiey · 2010 · Neuropharmacology
16. Neuropeptide Y (NPY) Suppresses Experimental Autoimmune Encephalomyelitis: NPY1 Receptor-Specific Inhibition of Autoreactive Th1 Responses In Vivo
    Sammy Bedoui, Sachiko Miyake, Youwei Lin, Katsuichi Miyamoto, Shinji Oki, Noriyuki Kawamura, Annette Gabriele Beck‐Sickinger, Stephan von Hörsten, Takashi Yamamura · 2003 · The Journal of Immunology
17. CD5-CK2 Binding/Activation-Deficient Mice Are Resistant to Experimental Autoimmune Encephalomyelitis: Protection Is Associated with Diminished Populations of IL-17-Expressing T Cells in the Central Nervous System
    Robert C. Axtell, Liang Zhong Xu, Scott R. Barnum, Chander Raman · 2006 · The Journal of Immunology
18. Synthetic fibronectin peptides interrupt inflammatory cell infiltration in transforming growth factor beta 1 knockout mice.
    K L Hines, Ashok B. Kulkarni, James B. McCarthy, H Tian, Jerrold Michael Ward, Marielle Christ, Nancy L McCartney-Francis, Leo T. Furcht, Stefan Karlsson, Sharon M. Wahl · 1994 · Proceedings of the National Academy of Sciences
19. Human Mesenchymal Stem Cells Infiltrate the Spinal Cord, Reduce Demyelination, and Localize to White Matter Lesions in Experimental Autoimmune Encephalomyelitis
    David J. Gordon, Gordana Pavlovska, James B. Uney · 2010 · Journal of Neuropathology & Experimental Neurology
20. Suppression of experimental allergic encephalomyelitis by mitoxantrone
    Susan C. Ridge, Adolph E. Sloboda, Richard A. McReynolds, Seymour Levine, Arnold L. Oronsky, Suresh S. Kerwar · 1985 · Clinical Immunology and Immunopathology
21. Hydroxyzine inhibits experimental allergic encephalomyelitis (EAE) and associated brain mast cell activation
    Violetta Dimitriadou, Xinzhu Pang, Theoharis Constantin Theoharides · 2000 · International Journal of Immunopharmacology
22. Cytokine Gene Therapy in Experimental Allergic Encephalomyelitis by Injection of Plasmid DNA-Cationic Liposome Complex into the Central Nervous System
    J. Ludovic Croxford, Kostas A. Triantaphyllopoulos, Osvaldo Luis Podhajcer, Marc Feldmann, David Baker, Yuti Chernajovsky · 1998 · The Journal of Immunology
23. Stem Cell Transplantation in Experimental Models of Autoimmune Disease
    Dirk W. van Bekkum · 2000 · Journal of Clinical Immunology
24. Some Misconceptions about Understanding Autoimmunity through Experiments with Knockouts
    Lawrence Steinman · 1997 · The Journal of Experimental Medicine
25. Vaccination with DNA Encoding an Immunodominant Myelin Basic Protein Peptide Targeted to Fc of Immunoglobulin G Suppresses Experimental Autoimmune Encephalomyelitis
    Anna Lobell, Robert Weissert, Maria K. Storch, Cecilia Svanholm, Katrien L. de Graaf, Hans Lassmann, Roland Andersson, Tomas P Olsson, Hans Wigzell · 1998 · The Journal of Experimental Medicine
26. EXPERIMENTAL ALLERGIC ENCEPHALITIS
    Lynn E. S̄pitler, Christine M. von Muller, H. Hugh Fudenberg · 1972 · The Journal of Experimental Medicine
27. Overexpression of CNTF in Mesenchymal Stem Cells reduces demyelination and induces clinical recovery in experimental autoimmune encephalomyelitis mice
    Zhengqi Lu, Xueqiang Hu, Cansheng Zhu, Dunjing Wang, Xueping Zheng, Quentin Liu · 2008 · Journal of Neuroimmunology
28. Blocking ion channel KCNN4 alleviates the symptoms of experimental autoimmune encephalomyelitis in mice
    Eva‐Pia Reich, Long Cui, Lily P. H. Yang, Catherine Pugliese‐Sivo, Andrei Golovko, Mary Petro, Galya Vassileva, Inhou Chu, Amin A. Nomeir, Li‐Kang Zhang et al. · 2005 · European Journal of Immunology
29. Immunoregulation of CNS autoimmunity by helminth and mycobacterial infections
    Diane L. Sewell, Emily K. Reinke, Laura H. Hogan, Mátyás Sándor, Zsuzsa Fábry · 2002 · Immunology Letters
30. The antidepressant venlafaxine ameliorates murine experimental autoimmune encephalomyelitis by suppression of pro-inflammatory cytokines
    Patrick Vollmar, Stefan Nessler, Sudhakar Reddy Kalluri, Hans‐Peter Hartung, Bernhard Hemmer · 2008 · The International Journal of Neuropsychopharmacology
31. T suppressor hybridomas and interleukin‐2‐dependent lines induced by copolymer 1 or by spinal cord homogenate down‐regulate experimental allergic encephalomyelitis
    Rina Aharoni, Dvora Teitelbaum, Ruth Arnon · 1993 · European Journal of Immunology
32. An open‐trial evaluation of mitoxantrone in the treatment of progressive MS
    John H. Noseworthy, M. B. Hopkins, Margaret K. Vandervoort et al. · 1993 · Neurology
33. Glucocorticoids in the control of neuroinflammation
    Denise Tischner, Holger Michael Reichardt · 2007 · Molecular and Cellular Endocrinology
34. Central nervous system gene therapy with interleukin-4 inhibits progression of ongoing relapsing–remitting autoimmune encephalomyelitis in Biozzi AB/H mice
    Roberto Furlan, Pietro Luigi Poliani, Peggy Marconi, Alessandra Bergami, Francesca Ruffini, Luciano Adorini, Glorioso Jc, Gıancarlo Comı, Gianvito Martino · 2001 · Gene Therapy
35. Effect of Disease Stage on Clinical Outcome After Syngeneic Bone Marrow Transplantation for Relapsing Experimental Autoimmune Encephalomyelitis
    Richard K. Burt, Josette Padilla, Wendy Smith Begolka · 1998 · Blood
36. High Dose IVIG in the Post Partum Period for Prevention of Exacerbations in MS
    Jürgen Haas · 2000 · Multiple Sclerosis Journal
37. Prazosin, an alpha 1-adrenergic receptor antagonist, suppresses experimental autoimmune encephalomyelitis in the Lewis rat.
    Celia F. Brosnan, Ellen A. Goldmuntz, Wendy Cammer · 1985 · Proceedings of the National Academy of Sciences
38. A randomized blinded trial of combination therapy with cyclophosphamide in patients with active multiple sclerosis on interferon beta
    Duane R. Smith, Bianca Weinstock‐Guttman, Jeffrey Allen Cohen et al. · 2005 · Multiple Sclerosis Journal
39. Luteolin as a therapeutic option for multiple sclerosis
    Theoharis Constantin Theoharides · 2009 · Journal of Neuroinflammation
40. Intravenous immunoglobulin treatment in multiple sclerosis.
    Anat Achiron, I R Cohen, Ofer Lider, E Melamed · 1995 · PubMed
41. Differential effects of treatment with a small-molecule VLA-4 antagonist before and after onset of relapsing EAE
    Bradley E. Theien, Carol L. Vanderlugt, Cheryl L. Nickerson‐Nutter · 2003 · Blood
42. Suppression of acute and relapsing experimental allergic encephalomyelitis with mitoxantrone
    FRED D. LUBLIN, Malti Lavasa, Craig Viti, Robert L. Knobler · 1987 · Clinical Immunology and Immunopathology
43. Autoimmune tolerance eliminates relapses but fails to halt progression in a model of multiple sclerosis
    Gareth Pryce, Janet K. O'Neill, J. Ludovic Croxford, Sandra Amor, Deborah J.R. Hankey, Emma East, Gavin Giovannoni, David Baker · 2005 · Journal of Neuroimmunology
44. Intrathecal Interferon in Multiple Sclerosis
    L. Jacobs, J A O'Malley, Arnold I. Freeman · 1982 · Archives of Neurology
45. Modulation of Blood-Brain Barrier Dysfunction and Neurological Deficits during Acute Experimental Allergic Encephalomyelitis by the N-Methyl-d-aspartate Receptor Antagonist Memantine
    Carolyn Paul, C. Bolton · 2002 · Journal of Pharmacology and Experimental Therapeutics
46. Axonal damage is reduced following glatiramer acetate treatment in C57/bl mice with chronic-induced experimental autoimmune encephalomyelitis
    Yossi Gilgun‐Sherki, Hana Panet, Vered Holdengreber, Ronit Galili-Mosberg, Daniel Offen · 2003 · Neuroscience Research
47. Therapeutic effect of the D2-dopamine agonist bromocriptine on acute and relapsing experimental allergic encephalomyelitis
    C.D. Dijkstra, E R van der Voort, Corline J.A. De Groot · 1994 · Psychoneuroendocrinology
48. Calcium channel blockers ameliorate disease in a mouse model of multiple sclerosis
    Elimor Brand‐Schieber, Peter Werner · 2004 · Experimental Neurology
49. Measurement of Spinal Cord Atrophy in Multiple Sclerosis
    Xia Lin, Christopher R. Tench, Nikos Evangelou · 2004 · Journal of Neuroimaging
50. Pilot Study of Minocycline in Relapsing-Remitting Multiple Sclerosis
    Yunyan Zhang, Luanne M. Metz, Voon Wee Yong, Robert B. Bell, Michael Yeung, David G. Patry, Joseph Ross Mitchell · 2008 · Canadian Journal of Neurological Sciences / Journal Canadien des Sciences Neurologiques
51. Suppression of Experimental Allergic Encephalomyelitis by Interferon
    Sergio L. Abreu · 1982 · Immunological Communications
52. Effective combination of minocycline and interferon-β in a model of multiple sclerosis
    Fabrizio Giuliani, Sue Anne Fu, Luanne M. Metz, Voon Wee Yong · 2005 · Journal of Neuroimmunology
53. Chemokine expression in GKO mice (lacking interferon-gamma) with experimental autoimmune encephalomyelitis
    Andrzej R Glabinski, Michelle L. Krakowski, Yulong Han, Trevor Owens, Richard M. Ransohoff · 1999 · Journal of NeuroVirology
54. T cell selection during the evolution of CD8+ T cell memory in vivo
    Margaret F. C. Callan, Nicola E. Annels, Neil Matthew Steven, Linda Tan, Jamie Wilson, Andrew James McMichael, Alan B. Rickinson · 1998 · European Journal of Immunology
55. Role of magnetic resonance imaging in the diagnosis and monitoring of multiple sclerosis: Consensus report of the White Matter Study Group
    Massimo Filippi, Vincent Dousset, Henry F. McFarland, David H. Miller, Robert I. Grossman · 2002 · Journal of Magnetic Resonance Imaging
56. Oral Administration of Myelin Basic Protein Is Superior to Myelin in Suppressing Established Relapsing Experimental Autoimmune Encephalomyelitis
    Jacqueline Benson, Scott S. Stuckman, Karen L Cox, Richard M. Wardrop, Ingrid E. Gienapp, Anne Haney Cross, John L. Trotter, Caroline C. Whitacre · 1999 · The Journal of Immunology
57. Are current disease‐modifying therapeutics in multiple sclerosis justified on the basis of studies in experimental autoimmune encephalomyelitis?
    Nasr Farooqi, Bruno Gran, Cris S. Constantinescu · 2010 · Journal of Neurochemistry
58. Increasing CNS Noradrenaline Reduces EAE Severity
    Maria Vittoria Simonini, Paul E. Polak, Anthony J Sharp, Susan O. McGuire, Elena Galea, Douglas L. Feinstein · 2009 · Journal of Neuroimmune Pharmacology
59. An experimental model of secondary progressive multiple sclerosis that shows regional variation in gliosis, remyelination, axonal and neuronal loss
    David W. Hampton, Jane Anderson, Gareth Pryce, Karen‐Amanda Irvine, Gavin Giovannoni, James W. Fawcett, Alastair Compston, Robin J.M. Franklin, David Baker, Siddharthan Chandran · 2008 · Journal of Neuroimmunology
60. Fingolimod (FTY720), sphingosine 1-phosphate receptor modulator, shows superior efficacy as compared with interferon-β in mouse experimental autoimmune encephalomyelitis
    Kenji Chiba, Hirotoshi Kataoka, Noriyasu Seki, Kyoko Shimano, Mamoru Koyama, Atsushi Fukunari, Kunio Sugahara, Takahisa Sugita · 2010 · International Immunopharmacology
61. CD4+CD25+ regulatory T cells contribute to the therapeutic effects of glatiramer acetate in experimental autoimmune encephalomyelitis
    Youngheun Jee, Wenhua Piao, Rex Liu, Xue‐Feng Bai, S. Rhodes, Raymond F. Rodebaugh, Denise I. Campagnolo, Fu‐Dong Shi, Timothy L. Vollmer · 2007 · Clinical Immunology
62. The length of treatment determines whether IFN-beta prevents or aggravates experimental autoimmune encephalomyelitis in Lewis rats
    Sigrid R. Ruuls, Miranda C.D.C. de Labie, K S Weber · 1996 · The Journal of Immunology
63. Selective elimination of macrophages by dichlormethylene diphosphonate-containing liposomes suppresses experimental autoimmune neuritis
    Stefan Jung, Ingeborg Huitinga, Beate G. Schmidt, Jürgen Zielasek, Christine D. Dijkstra, Klaus Viktor Toyka, Hans‐Peter Hartung · 1993 · Journal of the Neurological Sciences
64. Multiple sclerosis – a response-to-damage model
    Bert A. ‘t Hart, Rogier Q. Hintzen, Jon D. Laman · 2009 · Trends in Molecular Medicine
65. Therapy with antibody against leukocyte integrin VLA-4 (CD49d) is effective and safe in virus-facilitated experimental allergic encephalomyelitis
    Merja Soilu‐Hänninen, Matias Röyttä, Aimo A Salmi · 1997 · Journal of Neuroimmunology
66. Therapeutic vaccination with a trivalent T‐cell receptor (TCR) peptide vaccine restores deficient FoxP3 expression and TCR recognition in subjects with multiple sclerosis
    Arthur A. Vandenbark, Nicole E. Culbertson, Richard M. Bartholomew et al. · 2007 · Immunology
67. Fast Progression of Recombinant Human Myelin/Oligodendrocyte Glycoprotein (MOG)-Induced Experimental Autoimmune Encephalomyelitis in Marmosets Is Associated with the Activation of MOG34–56-Specific Cytotoxic T Cells
    Yolanda S. Kap, Paul Smith, S. Anwar Jagessar, Ed J. Remarque, Erwin L. A. Blezer, Gustav J. Strijkers, Jon D. Laman, Rogier Q. Hintzen, Jan Bauer, Herbert Brok et al. · 2008 · The Journal of Immunology
68. Chronic-relapsing experimental autoimmune encephalomyelitis (CR-EAE): treatment and induction of tolerance, with high dose cyclophosphamide followed by syngeneic bone marrow transplantation
    Dimitrios M. Karussis, Shimon Slavin, Avraham Ben‐Nun · 1992 · Journal of Neuroimmunology
69. Effects of the Angiotensin Converting Enzyme Inhibitor Captopril on Experimental Autoimmune Encephalomyelitis
    Cris S. Constantinescu, Elvira S. Ventura, Brendan A. Hilliard · 1995 · Immunopharmacology and Immunotoxicology
70. Immunosuppressive activity of 13-cis-retinoic acid and prevention of experimental autoimmune encephalomyelitis in rats.
    Luca Massacesi, Emanuela Castigli, Marco Vergelli, J. Olivotto, Anna Laura Abbamondi, F Sarlo, L. A. Amaducci · 1991 · Journal of Clinical Investigation
71. Effect of mitoxantrone on MRI in progressive MS
    Hilmar Krapf, Sean Morrissey, O Zenker, T Zwingers, R Gonsette, HP Hartung, the MIMS Study Group · 2005 · Neurology
72. Age Dependence of Clinical and Pathological Manifestations of Autoimmune Demyelination
    Mary Elizabeth Smith, Nancy L. Eller, Henry F. McFarland, Michael K. Racke, Cedric S. Raine · 1999 · American Journal Of Pathology
73. Neuroprotection and neurogeneration in MS and its animal model EAE effected by glatiramer acetate
    Ruth Arnon, Rina Aharoni · 2009 · Journal of Neural Transmission
74. Oral laquinimod in patients with relapsing-remitting multiple sclerosis: 36-week double-blind active extension of the multi-centre, randomized, double-blind, parallel-group placebo-controlled study
    Giancarlo Comi, Oded Abramsky, Txomin Arbizu et al. · 2010 · Multiple Sclerosis Journal
75. Early administration of IL-12 suppresses EAE through induction of interferon-γ
    Bruno Gran, Niansheng Chu, Guang‐Xian Zhang, Shuo Yu, Yonghai Li, Xiaohan Chen, Malek Kamoun, Abdolmohamad M. Rostami · 2004 · Journal of Neuroimmunology
76. A double-blind clinical trial of mitoxantrone versus methylprednisolone in relapsing, secondary progressive multiple sclerosis.
    F.A. Van De Wyngaert, Claire Beguin, Marie Beatrice D'hooghe · 2001 · PubMed
77. Downregulation of IL-17 and IL-6 in the central nervous system by glatiramer acetate in experimental autoimmune encephalomyelitis
    Sakhina Begum-Haque, Alok Sharma, Isaac R. Kasper, David Foureau, Daniel W. Mielcarz, Azizul Haque, Lloyd H. Kasper · 2008 · Journal of Neuroimmunology
78. Suppression of relapsing experimental autoimmune encephalomyelitis in the SJL/J mouse by oral administration of type I interferons
    Staley A. Brod, Dennis K. Burns · 1994 · Neurology
79. Experimental Autoimmune Encephalomyelitis in the Common Marmoset, a Bridge Between Rodent EAE and Multiple Sclerosis for Immunotherapy Development
    Yolanda S. Kap, Jon D. Laman, Bert A. ‘t Hart · 2009 · Journal of Neuroimmune Pharmacology
80. An Assessment of the Mechanistic Differences Between Two Integrin α4β1 Inhibitors, the Monoclonal Antibody TA-2 and the Small Molecule BIO5192, in Rat Experimental Autoimmune Encephalomyelitis
    Diane R. Leone, Keith Giza, Alan Gill et al. · 2003 · Journal of Pharmacology and Experimental Therapeutics
81. Effect of mitoxantrone on MRI in progressive MS: Results of the MIMS trial
    Stephen E. Nadeau · 2006 · Neurology
82. Syngeneic bone marrow transplantation eliminates Vβ8.2 T lymphocytes from the spinal cord of Lewis rats with experimental allergic encephalomyelitis
    Richard K. Burt, William H. Burns, Peter P. Ruvolo · 1995 · Journal of Neuroscience Research
83. Azathioprine for multiple sclerosis
    Ilaria Casetta, Gerardo Iuliano, Graziella Filippini · 2009 · Journal of Neurology Neurosurgery & Psychiatry
84. FTY720 ameliorates MOG‐induced experimental autoimmune encephalomyelitis by suppressing both cellular and humoral immune responses
    Dimitrios Papadopoulos, Jon Rundle, Ryan Patel, Ian C. B. Marshall, Jennifer L. Stretton, Rachel Eaton, Jill C. Richardson, Maria Gonzalez, Karen L. Philpott, Richard Reynolds · 2009 · Journal of Neuroscience Research
85. Pentoxifylline inhibits experimental allergic encephalomyelitis
    Serge Nataf, J.P. Louboutin, Dominique Chabannes · 2009 · Acta Neurologica Scandinavica
86. The effect of Cop 1, a synthetic polypeptide, on chronic relapsing experimental allergic encephalomyelitis in guinea pigs
    A.B. Keith, Ruth Arnon, Dvora Teitelbaum, ERNEST A. CASPARY, Henryk M. Wisniewski · 1979 · Journal of the Neurological Sciences
87. Regional suppression, therapy after onset and prevention of relapses in experimental allergic encephalomyelitis by mitoxantrone
    Seymour Levine, Arthur Saltzman · 1986 · Journal of Neuroimmunology
88. Spotlight on teriflunomide.
    Emma Clare Tallantyre, Nikos Evangelou, Cris S. Constantinescu · 2008 · PubMed
89. Loss of Na+ channel β2 subunits is neuroprotective in a mouse model of multiple sclerosis
    Heather A. O’Malley, Andrew B. Shreiner, Gwo-Hsiao Chen, Gary B. Huffnagle, Lori L. Isom · 2008 · Molecular and Cellular Neuroscience
90. Amino acid copolymer-specific IL-10-secreting regulatory T cells that ameliorate autoimmune diseases in mice
    Joel N. H. Stern, Derin B. Keskin, Hong Zhang, HuiJuan Lv, Zenichiro Kato, Jack L. Strominger · 2008 · Proceedings of the National Academy of Sciences
91. Reversal of experimental allergic encephalomyelitis with non-mitogenic, non-depleting anti-CD3 mAb therapy with a preferential effect on Th1 cells that is augmented by IL-4
    Giang T. Tran, Nicole M. Carter, Xiao Yan He · 2001 · International Immunology
92. Late B Cell Depletion with a Human Anti-Human CD20 IgG1κ Monoclonal Antibody Halts the Development of Experimental Autoimmune Encephalomyelitis in Marmosets
    Yolanda S. Kap, Nikki van Driel, Erwin L. A. Blezer, Paul W.H.I. Parren, Wim K. Bleeker, Jon D. Laman, Jenny L. Craigen, Bert A. ‘t Hart · 2010 · The Journal of Immunology
93. Experimental models of multiple sclerosis.
    Hans Lassmann · 2007 · Revue neurologique (Paris)
94. Mitoxantrone for multiple sclerosis
    Filippo Martinelli Boneschi, Marco Rovaris, Ruggero Capra · 2005 · Cochrane Database of Systematic Reviews
95. Hematopoietic Stem Cell Transplantation for Multiple Sclerosis: Collaboration of the CIBMTR and EBMT to Facilitate International Clinical Studies
    Marcelo C. Pasquini, Linda M. Griffith, Douglas Lorne Arnold, Harold L. Atkins, James D. Bowen, Jacqueline T. Chen, Mark Steven Freedman, George H. Kraft, Gianluigi Mancardi, Roland Martinꝉ et al. · 2010 · Transplantation and Cellular Therapy
96. Modulation of Susceptibility and Resistance to an Autoimmune Model of Multiple Sclerosis in Prototypically Susceptible and Resistant Strains by Neutralization of Interleukin-12 and Interleukin-4, Respectively
    Cris S. Constantinescu, Brendan A. Hilliard, Elvira S. Ventura, Maria Wysocka, Louise C. Showe, Ehud Lavi, Toshiki Fujioka, Phillip Scott, Giorgio Trinchieri, Abdolmohamad M. Rostami · 2001 · Clinical Immunology
97. Acute/relapsing experimental autoimmune encephalomyelitis: Induction of long lasting, antigen-specific tolerance by syngeneic bone marrow transplantation
    Dimitrios M. Karussis, Urania Vourka-Karussis, Rachel Mizrachi-Koll · 1999 · Multiple Sclerosis Journal
98. Discontinuation of treatment with IFN-β leads to exacerbation of experimental autoimmune encephalomyelitis in Lewis rats. Rapid reversal of the antiproliferative activity of IFN-β and excessive expansion of autoreactive T cells as disease promoting mechanisms
    Peter H. van der Meide, Miranda C.D.C. de Labie, Sigrid R. Ruuls · 1998 · Journal of Neuroimmunology
99. Relapse rates and enhancing lesions in a phase II trial of natalizumab in multiple sclerosis
    Paul W O'Connor, David H. Miller, Katherine A. Riester, Minhua Yang, Michael A. Panzara, Catherine M. Dalton, Katherine Miszkiel, Omar Khan, George P. Rice, William A. Sheremata et al. · 2005 · Multiple Sclerosis Journal
100. Amelioration of proteolipid protein 139–151-induced encephalomyelitis in SJL mice by modified amino acid copolymers and their mechanisms
     Joel N. H. Stern, Zsolt Illés, Jayagopala Reddy et al. · 2004 · Proceedings of the National Academy of Sciences
101. Suppression of autoimmune encephalomyelitis by a neurokinin-1 receptor antagonist — A putative role for substance P in CNS inflammation
     Stefan Nessler, Christine Stadelmann, Alwina Bittner · 2006 · Journal of Neuroimmunology
102. Efficacy of Azathioprine on Multiple Sclerosis New Brain Lesions Evaluated Using Magnetic Resonance Imaging
     Luca Massacesi, Alessandro Parigi, Alessandro Barilaro · 2005 · Archives of Neurology
103. Measurement of Spinal Cord Atrophy in Multiple Sclerosis
     Xia Lin, Christopher R. Tench, Nikos Evangelou · 2004 · Journal of Neuroimaging
104. Effect of treatment with copolymer 1 (Cop-1) on the in vivo and in vitro manifestations of experimental allergic encephalomyelitis (EAE)
     Robert P. Lisak, Burton Zweiman, Nadine Blanchard, LUCY BALIAN RORKE · 1983 · Journal of the Neurological Sciences
105. Stem cell based delivery of IFN-β reduces relapses in experimental autoimmune encephalomyelitis
     Tapas Kumar Makar, David N. Trisler, Christopher T. Bever, James E. Goolsby, Karna Tushar Sura, Shailesh Balasubramanian, Shireen Sultana, Nirav C. Patel, David Ford, Ishwar S. Singh et al. · 2008 · Journal of Neuroimmunology
106. T-cell clones persisting in the circulation after autologous hematopoietic SCT are undetectable in the peripheral CD34+ selected graft
     Amy N. Dubinsky, Richard K. Burt, Roland Martinꝉ, Paolo Antonio Muraro · 2009 · Bone Marrow Transplantation
107. HSV-1-mediated IL-1 receptor antagonist gene therapy ameliorates MOG35–55-induced experimental autoimmune encephalomyelitis in C57BL/6 mice
     Roberto Furlan, Alessandra Bergami, Elena Brambilla, Erica Butti, Maria Grazia De Simoni, M Campagnoli, Peggy Marconi, Gıancarlo Comı, Gianvito Martino · 2006 · Gene Therapy
108. The Role of Osteopontin in Experimental Autoimmune Encephalomyelitis (EAE) and Multiple Sclerosis (MS)
     Manjit Kaur Braitch, Cris S. Constantinescu · 2010 · Inflammation & Allergy - Drug Targets
109. Current and future disease-modifying therapies in multiple sclerosis
     Su‐Yin Lim, Cris S. Constantinescu · 2010 · International Journal of Clinical Practice
110. The Use of Clinically Approved Small Particles of Iron Oxide (SPIO) for Labeling of Mesenchymal Stem Cells Aggravates Clinical Symptoms in Experimental Autoimmune Encephalomyelitis and Influences Their In Vivo Distribution
     Richard Schäfer, Miriam Ayturan, Rüdiger Bantleon, Rainer Kehlbach, J. Pintaske, Sabine Conrad, Hartwig Wolburg, Jakub Wiskirchen, Robert Weissert · 2008 · Cell Transplantation
111. Beta-interferon unbalances the peripheral T cell proinflammatory response in experimental autoimmune encephalomyelitis
     Francisco M. Martín-Saavedra, Natalia Flores, Beatriz Dorado, César Eguiluz, Beatriz Bravo, Antonio García‐Merino, Sara Ballester · 2007 · Molecular Immunology
112. Transgenic expression of CCL2 in the central nervous system prevents experimental autoimmune encephalomyelitis
     Adam Elhofy, Jintang Wang, Mari Tani, Brian T. Fife, Kevin J Kennedy, Jami L. Bennett, DeRen Huang, Richard M. Ransohoff, William J. Karpus · 2004 · Journal of Leukocyte Biology
113. Experimental autoimmune encephalomyelitis as a testing paradigm for adjuvants and vaccines
     Libbey, Jane E., Fujinami, Robert S. · 2011 · Vaccine
114. A double-blind, placebo-controlled trial of extracorporeal photopheresis in chronic progressive multiple sclerosis
     A M Rostami, Richard A. Sater, Shawn J. Bird · 1999 · Multiple Sclerosis Journal
115. Expression of Activity-Dependent Neuroprotective Protein in the Immune System: Possible Functions and Relevance to Multiple Sclerosis
     Manjit Kaur Braitch, Kiyokazu Kawabe, Mukanthu Nyirenda, Lucie Jean-Gilles, R. A. Robins, Bruno Gran, Sean Patrick Murphy, Louise C. Showe, Cris S. Constantinescu · 2009 · NeuroImmunoModulation
116. Massive Apoptosis in Lymphoid Organs in Animal Models for Primary and Secondary Progressive Multiple Sclerosis
     Ikuo Tsunoda, Jane E. Libbey, Li‐Qing Kuang, Emily Jane Terry, Robert S. Fujinami · 2005 · American Journal Of Pathology
117. Prolonged reversal of chronic experimental allergic encephalomyelitis using a small molecule inhibitor of α4 integrin
     P.S. Piraino, Ted A. Yednock, Stephen B. Freedman, Elizabeth K. Messersmith, Michael A. Pleiss, Chris Vandevert, Eugene D. Thorsett, Stephen J. Karlik · 2002 · Journal of Neuroimmunology
118. All-trans Retinoic Acid Potentiates the Ability of Interferon Beta-1b to Augment Suppressor Cell Function in Multiple Sclerosis
     Zhi Xiang Qu, Amit S. Dayal, Mark A. Jensen, Barry G.W. Arnason · 1998 · Archives of Neurology
119. Substance P receptor mediated maintenance of chronic inflammation in EAE
     Emily K. Reinke, Matthew J. Johnson, Changying Ling · 2006 · Journal of Neuroimmunology
120. Modified amino acid copolymers suppress myelin basic protein 85–99-induced encephalomyelitis in humanized mice through different effects on T cells
     Zsolt Illés, Joel N. H. Stern, Jayagopala Reddy et al. · 2004 · Proceedings of the National Academy of Sciences
121. Bladder dysfunction in mice with experimental autoimmune encephalomyelitis
     Cengiz Zubeyir Altuntas, Firouz Daneshgari, Guiming Liu, Adebola C. Fabiyi, Michael Kavran, Justin M. Johnson, Muhammet Fatih Gulen, Ritika Jaini, Xiaoxia Li, Tara Lee Frenkl et al. · 2008 · Journal of Neuroimmunology
122. Beneficial effect of modified peptide inhibitor of α4 integrins on experimental allergic encephalomyelitis in Lewis rats
     Luc J. W. van der Laan, Annette van der Goes, Marca H. M. Wauben · 2001 · Journal of Neuroscience Research
123. Protection against autoimmune disease by bacterial agents. II. PPD and pertussis toxin as proteins active in protecting mice against experimental autoimmune encephalomyelitis
     Avraham Ben‐Nun, Sara Yossefi, Dan Lehmann · 1993 · European Journal of Immunology
124. Disease Progression After Bone Marrow Transplantation in a Model of Multiple Sclerosis Is Associated With Chronic Microglial and Glial Progenitor Response
     Riccardo Cassiani‐Ingoni, Paolo Antonio Muraro, Tim Magnus, Susan A. Reichert-Scrivner, Jens Schmidt, Jaebong Huh, Jacqueline A. Quandt, András Bratincsák, Tal Shahar, Fabrizio Eusebi et al. · 2007 · Journal of Neuropathology & Experimental Neurology
125. Emerging multiple sclerosis oral therapies
     Kottil W Rammohan, Jennifer Shoemaker · 2009 · Neurology
126. Immunosuppressive treatment in multiple sclerosis
     Howard L. Weiner · 2004 · Journal of the Neurological Sciences
127. The primary lesion theory of autoimmunity: a speculative hypothesis
     Wilkin, T. J. · 1990 · Autoimmunity
128. Characterization of acute versus chronic relapsing autoimmune encephalomyelitis in DA rats
     Naoyuki Tanuma, Taekyun Shin, Yoh Matsumoto · 2000 · Journal of Neuroimmunology
129. Suppression of Experimental Autoimmune Encephalomyelitis by Intravenously Administered Polyclonal Immunoglobulins
     Anat Achiron, Felix Mor, Raanan Margalit · 2000 · Journal of Autoimmunity
130. The TLR7 agonist, imiquimod, increases IFN-β production and reduces the severity of experimental autoimmune encephalomyelitis
     Kate O’Brien, Denise C. Fitzgerald, Abdolmohamad M. Rostami, Bruno Gran · 2010 · Journal of Neuroimmunology
131. Variable effects of cyclophosphamide in rodent models of experimental allergic encephalomyelitis
     Katia Mangano, Alessandra Susie Quesado Nicoletti, Francesco Patti et al. · 2009 · Clinical & Experimental Immunology
132. Extracorporeal photochemotherapy: a safety and tolerability pilot study with preliminary efficacy results in refractory relapsing-remitting multiple sclerosis
     Guido Cavaletti, Paolo Perseghin, Maria Dassi, Rosella Cavarretta, Maura Frigo, Domenico Caputo, Lorenzo Stanzani, Elena Tagliabue, C Zoia, Marco Grimaldi et al. · 2006 · Neurological Sciences
133. An analysis of the role of tumor necrosis factor in the phenotypic expression of actively induced experimental allergic orchitis and experimental allergic encephalomyelitis
     Cory Teuscher, William F. Hickey, Robert Korngold · 1990 · Clinical Immunology and Immunopathology
134. Hematopoietic stem cell transplantation for multiple sclerosis: current status and future challenges.
     P. Muraro, R. C. Ingoni, Roland Martin · 2003 · Current Opinion in Neurology
135. Interferon β Modulates Experimental Autoimmune Encephalomyelitis by Altering the Pattern of Cytokine Secretion
     Clarissa Lin Yasuda, A AL-Sabbagh, E. Capelas de Oliveira · 1999 · Immunological Investigations
136. N-type Calcium Channel in the Pathogenesis of Experimental Autoimmune Encephalomyelitis*
     Naoki Tokuhara, Kana Namiki, Mai Uesugi, Chihiro Miyamoto, Makoto Ohgoh, Katsutoshi Ido, Takashi Yoshinaga, Toshihiko Yamauchi, Junro Kuromitsu, Sadao Kimura et al. · 2010 · Journal of Biological Chemistry
137. Oral Glatiramer Acetate in Experimental Autoimmune Encephalomyelitis: Clinical and Immunological Studies
     Dvora Teitelbaum, Rina Aharoni, Ety Klinger · 2004 · Annals of the New York Academy of Sciences
138. Preclinical Assessment of Therapeutic Antibodies against Human CD40 and Human Interleukin-12/23p40 in a Nonhuman Primate Model of Multiple Sclerosis
     Bert A. ‘t Hart, Rogier Q. Hintzen, Jon D. Laman · 2007 · Neurodegenerative Diseases
139. Antibody‐mediated suppression of Vβ5.2/5.3+ T cells in multiple sclerosis: Results from an MRI‐monitored phase II clinical trial
     Joep Killestein, Tomas P Olsson, Erik Wallström, Anders Svenningsson, Mohsen Khademi, Lance D. Blumhardt, Jan Fagius, Jan A. Hillert, Anne‐Marie Landtblom, Charlotte Edenius et al. · 2002 · Annals of Neurology
140. Azathioprine in Multiple Sclerosis
     Paolo Invernizz, Maria Donata Benedetti, Sarah Poli · 2008 · Mini-Reviews in Medicinal Chemistry
141. The Distribution of Inflammatory Demyelinated Lesions in the Central Nervous System of Rats with Antibody-Augmented Demyelinating Experimental Allergic Encephalomyelitis
     Annette P. Meeson, Sara J. Piddlesden, B. Paul Morgan · 1994 · Experimental Neurology
142. Effect of rat andβ-human interferons on hyperacute experimental allergic encephalomyelitis in rats
     Francoise Hertz, Romano Deghenghi · 1985 · Inflammation Research
143. Optic neuritis and chronic relapsing experimental allergic encephalomyelitis: relationship to clinical course and comparison with multiple sclerosis.
     Cedric S. Raine, Ute Traugott, Nussenblatt Rb · 1980 · PubMed
144. MPTP-induced central dopamine depletion exacerbates experimental autoimmune encephalomyelitis (EAE) in C57BL mice
     Ewa Bałkowiec-Iskra, Iwona Kurkowska‐Jastrzębska, Ilona Joniec‐Maciejak · 2007 · Inflammation Research
145. Differential efficacy of a synthetic antagonist of VLA‐4 during the course of chronic relapsing experimental autoimmune encephalomyelitis
     Barbara Cannella, Stefanie Gaupp, Ronald G. Tilton · 2002 · Journal of Neuroscience Research
146. Long term safety of IVIg therapy in multiple sclerosis: 10 years experience
     Uriel Katz, Irena Kishner, David Magalashvili · 2006 · Autoimmunity
147. Experimental allergic optic neuritis in guinea pigs: preliminary report.
     N. A. Rao, M. O.M. Tso, E L Zimmerman · 1977 · PubMed
148. Naked DNA vaccination differentially modulates autoimmune responses in experimental autoimmune encephalomyelitis
     Krzysztof W. Selmaj, Czeslawa Kowal, Agata Walczak · 2000 · Journal of Neuroimmunology
149. Gene-Based Intramuscular Interferon-β Therapy for Experimental Autoimmune Encephalomyelitis
     Ritika Jaini, Drew Hannaman, Justin M. Johnson · 2006 · Molecular Therapy
150. Immunologic effects of cyclophosphamide/ACTH in patients with chronic progressive multiple sclerosis
     David A. Hafler, John Orav, Robert E. Gertz · 1991 · Journal of Neuroimmunology
151. TNF-α: A Paradigm of Paradox and Complexity in Multiple Sclerosis and its Animal Models~!2009-10-07~!2009-11-23~!2010-07-14~!
     Su‐Yin Lim · 2010 · The Open Autoimmunity Journal
152. Effects of prazosin on the blood-brain barrier during experimental autoimmune encephalomyelitis
     Luz Cláudio, Celia F. Brosnan · 1992 · Brain Research
153. IL-12 reverses the suppressive effect of the CD40 ligand blockade on experimental autoimmune encephalomyelitis (EAE)
     Cris S. Constantinescu, Brendan A. Hilliard, Maria Wysocka · 1999 · Journal of the Neurological Sciences
154. Antisense oligonucleotide blockade of alpha 4 integrin prevents and reverses clinical symptoms in murine experimental autoimmune encephalomyelitis
     Kathleen J. Myers, Donna R. Witchell, Mark J. Graham · 2004 · Journal of Neuroimmunology
155. Histopathology of EAE
     Michael J. Day · 2008 · Springer eBooks
156. The Multifaceted Role of Interferon-γ in Central Nervous System Autoimmune Demyelination~!2009-09-01~!2009-11-02~!2010-07-14~!
     Lara Sanvito · 2010 · The Open Autoimmunity Journal
157. Autoimmune associations in multiple sclerosis
     Cris S. Constantinescu, Bruno Gran · 2010 · Nature Reviews Neurology
158. IMMUNOLOGICAL STUDIES WITH HERPES VIRUS WITH A CONSIDERATION OF THE HERPES-ENCEPHALITIS PROBLEM
     HANS H. ZINSSER, Fei-Fang Tang · 1926 · The Journal of Experimental Medicine
159. K+ channel-blocking alkoxypsoralens inhibit the immune response of encephalitogenic T line cells and lymphocytes from Lewis rats challenged for experimental autoimmune encephalomyelitis
     Ulf Strauß, Kirsten Wissel, Stefan Jung · 2000 · Immunopharmacology
160. Small but powerful: Short peptide hormones and their role in autoimmune inflammation
     Fred Lühder, D.H. Lee, Ralf Gold, Johannes Stegbauer, Ralf Andreas Linker · 2009 · Journal of Neuroimmunology
161. Studies on the encephalitogenic effects of purified preparations of human and bovine oligodendrocytes
     Cedric S. Raine, Henryk M. Wı́sniewski, Khalid Iqbal · 1977 · Brain Research
162. IFN-β modulates specific T cell responses in vitro but does not affect Experimental Autoimmune Encephalomyelitis in the SJL mouse
     Mariken E. Luca, L. H. Visser, Cornelis J. Lucas · 1999 · Journal of Neuroimmunology
163. Evaluating potential therapies for bladder dysfunction in a mouse model of multiple sclerosis with high-resolution ultrasonography
     Sarah Al‐Izki, Gareth Pryce, Gavin Giovannoni, David Baker · 2009 · Multiple Sclerosis Journal
164. T cell expression of CIITA represses Th1 immunity
     W. S. Park · 2004 · International Immunology
165. The Multifaceted Role of Interferon-γ in Central Nervous System Autoimmune Demyelination
     Lara Sanvito, Cris S. Constantinescu, Bruno Gran, Bert A. ‘t Hart · 2010 · The Open Autoimmunity Journal
166. Cyclophosphamide Treatment of MS: Current Therapeutic Approaches and Treatment Regimens.
     A I Elkhalifa, Weiner Hl · 2010 · PubMed
167. Gene-Based Delivery of IFN-β Is Efficacious in a Murine Model of Experimental Allergic Encephalomyelitis
     Caralee J. Schaefer, Toni Rose Hidalgo, Linda M. Cashion et al. · 2006 · Journal of Interferon & Cytokine Research
168. Activation thresholds determine susceptibility to peptide-induced tolerance in a heterogeneous myelin-reactive T cell repertoire
     David L. McCue, Kelli R. Ryan, David Cameron Wraith · 2004 · Journal of Neuroimmunology
169. Experimental Allergic Encephalitis; Treatment with Drugs Which Alter CNS Serotonin Levels
     Charles F. Scott, Neil R. Cashman, Lynn E. S̄pitler · 1982 · Journal of Immunopharmacology
170. TNF-α: A Paradigm of Paradox and Complexity in Multiple Sclerosis and its Animal Models
     Su‐Yin Lim, Cris S. Constantinescu · 2010 · The Open Autoimmunity Journal
171. The Austrian Immunoglobulin in MS (AIMS) Study: Final Analysis
     Siegrid Strasser‐Fuchs, Franz Fazekas, Florian Deisenhammer · 2000 · Multiple Sclerosis Journal
172. Large subpial plaques of demyelination in a new form of chronic experimental allergic encephalomyelitis in the guinea pig
     Ellsworth C. Alvord, Bernard F. Driscoll, Marian Wood Kies · 1985 · Neurochemical Pathology
173. Inactivation of neurogenic 5-hydroxytryptamine receptors in guinea pigs with experimental allergic encephalomyelitis (EAE) induced paralysis
     Marta Weinstock, Sandra R. Shoham-Moshonov, Dvora Teitelbaum · 1977 · Brain Research
174. Blockade of Ca2+‐activated K+ channels in T cells: an option for the treatment of multiple sclerosis?
     Lars Siim Madsen, Palle Christophersen, Søren‐Peter Olesen · 2005 · European Journal of Immunology
175. Potassium channel blockers inhibit adoptive transfer of experimental allergic encephalomyelitis by myelin-basic-protein-stimulated rat T lymphocytes
     Susan I. V. Judge, Jay Z. Yeh, Mark D. Mannie · 1997 · Journal of Biomedical Science
176. THE INFLUENCE OF CINANSERIN AND SELECTED PHARMACOLOGIC AGENTS ON EXPERIMENTAL ALLERGIC ENCEPHALOMYELITIS (EAE)
     Ronald G. Babington, Paul W. Wedeking · 1971 · Journal of Pharmacology and Experimental Therapeutics
177. The effect of short-term treatment with interferon beta 1a on acute experimental allergic encephalomyelitis.
     M Wender, S. Michalak, H Wygladalska-Jernas · 2001 · PubMed
178. Immuno-Therapeutic Potential of Haematopoietic and Mesenchymal Stem Cell Transplantation in MS
     Paolo Antonio Muraro, Antonio Uccelli · 2009 · Results and problems in cell differentiation
179. Suppression of experimental allergic encephalomyelitis by 15-deoxyspergualin
     Takashi Yamamura, Yao Da-Lin, Jun‐ichi Satoh · 1987 · Journal of the Neurological Sciences
180. Laquinimod, a new oral autoimmune modulator for the treatment of relapsing-remitting multiple sclerosis.
     Alex C. Tselis · 2010 · PubMed
181. Immunosuppressive activity of 13-cis-retinoic acid in rats: aspects of pharmacokinetics and pharmacodynamics
     Marco Vergelli, J. Olivotto, Emanuela Castigli · 1997 · Immunopharmacology
182. VIRUS III ENCEPHALITIS
     Thomas M. Rivers, Fred W. Stewart · 1928 · The Journal of Experimental Medicine
183. Therapeutic effects of 15-deoxyspergualin in acute and chronic relapsing experimental allergic encephalomyelitis (EAE) as models for multiple sclerosis (MS).
     H U Schorlemmer, Fritz R. Seiler · 1991 · PubMed
184. Experimental Autoimmune Encephalomyelitis
     Bruno Gran, Kate O’Brien, Denise C. Fitzgerald, A. M. Rostami · 2007 · Springer eBooks
185. Synaptic activity could hold the key to therapy for Huntington disease
     Kathryn Senior · 2010 · Nature Reviews Neurology
186. Immunomodulating effects of extracorporeal photochemotherapy in rat experimental allergic encephalomyelitis.
     Guido Cavaletti, Paolo Perseghin, F Buscemi et al. · 2001 · PubMed
187. Interferon in Experimental Autoimmune Encephalomyelitis: Intraventricular Administration
     Sergio L. Abreu, Immac J. Thampoe, PAUL KAPLAN · 1986 · Journal of Interferon Research
188. Multiple sclerosis findings in the spinal cord
     Laura J. Edwards, Christopher R. Tench, CP Gilmore, Nikos Evangelou, Cris S. Constantinescu · 2007 · Expert Review of Neurotherapeutics
189. Update on emerging therapies for multiple sclerosis
     Eppie Mildred Yiu, Brenda Banwell · 2010 · Expert Review of Neurotherapeutics
190. Experimental allergic encephalomyelitis in chickens.
     B Błaszczyk, J Giełdanowski, I Karakoz · 1978 · PubMed
191. Changes in leukocyte recirculation, NK cell activity, and HLA-DR expression in peripheral blood mononuclear cells of MS patients treated with poly ICLC
     Christopher T. Bever, Steven Jacobson, Elizabeth S. Mingioli · 1991 · International Journal of Immunopharmacology
192. POSTVACCINAL ENCEPHALITIS
     E ELST · 1931 · American Journal of Public Health and the Nations Health
193. A Paradoxical Effect of Systemic IL-23 in EAE -; Limitation of Autoimmune Inflammatory Demyelination~!2009-11-30~!2010-02-16~!2010-07-14~!
     Tarik Touil · 2010 · The Open Autoimmunity Journal
194. Editorial: [Dual and Opposite Actions of Cytokines in Autoimmune Inflammatory Demyelination]
     Bruno Gran · 2010 · The Open Autoimmunity Journal
195. Untitled work
     Komuro · 2001 · 10.1002/1529-0131(200112)44:12